Jeremie Jegu

Summary

Publications

  1. doi The effect of patient characteristics on second primary cancer risk in France
    Jeremie Jegu
    Registre des cancers du Bas Rhin, Laboratoire d épidémiologie et de santé publique, EA3430, FMTS, Universite de Strasbourg, 4 rue Kirschleger, Strasbourg, CEDEX 67085, France
    BMC Cancer 14:94. 2014
  2. doi Trends over three decades of the risk of second primary cancer among patients with head and neck cancer
    Jeremie Jegu
    Bas Rhin Cancer Registry, Department of Epidemiology and Public Health, EA 3430, Faculty of Medicine, University of Strasbourg, and Department of Public Health, University Hospital of Strasbourg, 1 Place de l Hopital, 67000 Strasbourg, France
    Oral Oncol 49:9-14. 2013
  3. pmc Slow-release oral morphine for opioid maintenance treatment: a systematic review
    Jeremie Jegu
    Department of Medical and Clinical Pharmacology, Centre d Evaluation et d Information sur Pharmacodépendance Addictovigilance, University Hospital of Toulouse, 31000 Toulouse, France
    Br J Clin Pharmacol 71:832-43. 2011
  4. doi Use of psychotropic drugs, systemic antihistamines and medications for cough in 6-year-old children: a survey in the Bas-Rhin Region, France
    Florence Binder-Foucard
    Laboratoire d épidémiologie et de santé publique EA 3430, Faculte de Medecine, Universite de Strasbourg, Strasbourg Cedex 67085, France
    Pharmacoepidemiol Drug Saf 21:1112-7. 2012

Detail Information

Publications4

  1. doi The effect of patient characteristics on second primary cancer risk in France
    Jeremie Jegu
    Registre des cancers du Bas Rhin, Laboratoire d épidémiologie et de santé publique, EA3430, FMTS, Universite de Strasbourg, 4 rue Kirschleger, Strasbourg, CEDEX 67085, France
    BMC Cancer 14:94. 2014
    ..We used a multivariate approach to compute these estimates and analyzed the effect of patient characteristics (gender, age at diagnosis, first cancer site, year of diagnosis and follow-up) on SPC risk...
  2. doi Trends over three decades of the risk of second primary cancer among patients with head and neck cancer
    Jeremie Jegu
    Bas Rhin Cancer Registry, Department of Epidemiology and Public Health, EA 3430, Faculty of Medicine, University of Strasbourg, and Department of Public Health, University Hospital of Strasbourg, 1 Place de l Hopital, 67000 Strasbourg, France
    Oral Oncol 49:9-14. 2013
    ..This raises the question of a modification to the risk of SPC, taking into account variations of patient characteristics related to the HPV-cancer epidemic...
  3. pmc Slow-release oral morphine for opioid maintenance treatment: a systematic review
    Jeremie Jegu
    Department of Medical and Clinical Pharmacology, Centre d Evaluation et d Information sur Pharmacodépendance Addictovigilance, University Hospital of Toulouse, 31000 Toulouse, France
    Br J Clin Pharmacol 71:832-43. 2011
    ..However, there was no comparison with other maintenance drugs. As most of the studies assessing SROM efficacy were uncontrolled, there is no definite evidence that SROM is an effective alternative to methadone for OMT...
  4. doi Use of psychotropic drugs, systemic antihistamines and medications for cough in 6-year-old children: a survey in the Bas-Rhin Region, France
    Florence Binder-Foucard
    Laboratoire d épidémiologie et de santé publique EA 3430, Faculte de Medecine, Universite de Strasbourg, Strasbourg Cedex 67085, France
    Pharmacoepidemiol Drug Saf 21:1112-7. 2012
    ..This survey aims to assess the prevalence of use of psychotropic drugs, antihistamines and medications for cough as well as parents' knowledge about the drugs used in 2009...